Literature DB >> 8195713

Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.

T Skorski1, P Kanakaraj, D H Ku, M Nieborowska-Skorska, E Canaani, G Zon, B Perussia, B Calabretta.   

Abstract

The p210bcr/abl tyrosine kinase appears to be responsible for initiating and maintaining the leukemic phenotype in chronic myelogenous leukemia (CML) patients. p21ras-p120GAP interactions play a central role in transducing mitogenic signals. Therefore, we investigated whether p21ras and p120GAP are regulated by p210bcr/abl, and whether this activation is functionally significant for CML cell proliferation. We report that transient expression of p210bcr/abl in fibroblast-like cells induces simultaneous activation of p21ras and inhibition of GTPase-promoting activity of p120GAP, and confirm these data showing that downregulation of p210bcr/abl expression in CML cells with bcr/abl antisense oligodeoxynucleotides induces both inhibition of p21ras activation and stimulation of GTPase-promoting activity of p120GAP. Tyrosine phosphorylation of two p120GAP-associated proteins, p190 and p62, which may affect p120GAP activity, also depends on p210bcr/abl tyrosine kinase expression. Direct dependence of these effects on the kinase activity is proven in experiments in which expression of c-MYB protein in fibroblast-like cells or downregulation of c-MYB expression resulting in analogous inhibition of CML cell proliferation does not result in the same changes. Use of specific antisense oligodeoxynucleotides to downregulate p21ras expression revealed a requirement for functional p21ras in the proliferation of Philadelphia chromosome-positive CML primary cells. Thus, the p210bcr/abl-dependent regulation of p120GAP activity is responsible, in part, for the maintenance of p21ras in the active GTP-bound form, a crucial requirement for CML cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195713      PMCID: PMC2191514          DOI: 10.1084/jem.179.6.1855

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  64 in total

1.  BCR-ABL and BCR proteins: biochemical characterization and localization.

Authors:  S Dhut; T Chaplin; B D Young
Journal:  Leukemia       Date:  1990-11       Impact factor: 11.528

2.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Stimulation of p21ras upon T-cell activation.

Authors:  J Downward; J D Graves; P H Warne; S Rayter; D A Cantrell
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

4.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

Authors:  J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

5.  Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

Authors:  M A Kelliher; J McLaughlin; O N Witte; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.

Authors:  R Ballester; D Marchuk; M Boguski; A Saulino; R Letcher; M Wigler; F Collins
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

7.  Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP).

Authors:  J B Gibbs; M S Marshall; E M Scolnick; R A Dixon; U S Vogel
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

8.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

Authors:  G A Martin; D Viskochil; G Bollag; P C McCabe; W J Crosier; H Haubruck; L Conroy; R Clark; P O'Connell; R M Cawthon
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

9.  A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.

Authors:  A J Muller; A M Pendergast; M H Havlik; L Puil; T Pawson; O N Witte
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

10.  NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).

Authors:  M Lanotte; V Martin-Thouvenin; S Najman; P Balerini; F Valensi; R Berger
Journal:  Blood       Date:  1991-03-01       Impact factor: 22.113

View more
  16 in total

1.  Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

Authors:  T Skorski; A Bellacosa; M Nieborowska-Skorska; M Majewski; R Martinez; J K Choi; R Trotta; P Wlodarski; D Perrotti; T O Chan; M A Wasik; P N Tsichlis; B Calabretta
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  ADP-ribosylation of the GTP-binding protein RhoA blocks cytoplasmic division in human myelomonocytic cells.

Authors:  M Aepfelbacher; M Essler; K Luber De Quintana; P C Weber
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

3.  Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.

Authors:  N Kashige; N Carpino; R Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.

Authors:  Shu-Yue Ren; Elisabeth Bolton; M Golam Mohi; Andrea Morrione; Benjamin G Neel; Tomasz Skorski
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Characterization of a novel member of the DOK family that binds and modulates Abl signaling.

Authors:  F Cong; B Yuan; S P Goff
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 6.  Mechanisms of transformation by the BCR/ABL oncogene.

Authors:  M Sattler; J D Griffin
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

7.  Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells.

Authors:  K R LaMontagne; G Hannon; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.

Authors:  A B Raitano; J R Halpern; T M Hambuch; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac.

Authors:  T Skorski; P Wlodarski; L Daheron; P Salomoni; M Nieborowska-Skorska; M Majewski; M Wasik; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation.

Authors:  D Raepple; F von Lintig; T Zemojtel; M Duchniewicz; A Jung; M Lübbert; G R Boss; J S Scheele
Journal:  Ann Hematol       Date:  2008-09-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.